Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CERITINIB vs CETUXIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CERITINIB vs CETUXIMAB: Safety Overview

Metric CERITINIB CETUXIMAB
Total FAERS Reports 2,796 14,553
Deaths Reported 786 2,104
Death Rate 28.1% 14.5%
Hospitalizations 804 5,157
Average Patient Age 55.6 yrs 62.6 yrs
% Female Patients 55.1% 31.5%
FDA Approval Date Apr 29, 2014 N/A
Manufacturer Novartis Pharmaceuticals Corporation ImClone LLC
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription